3 December 2018

Surgical Innovations Group plc ("Surgical Innovations" or "the "Company")

Appointment of Nominated Adviser and Broker

Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as Nominated Adviser and sole Broker to the Company with immediate effect.

For further information contact:

Surgical Innovations Group Plc

www.sigroupplc.com

Nigel Rogers, Executive Chairman

Tel: +44 (0)113 230 7597

Melanie Ross, COO and CFO

Walbrook PR (Financial PR & Investor Relations)

Tel: +44 (0)20 7933 8780 orsi@walbrookpr.com

Paul McManus

Mob: +44 (0)7980 541 893

Lianne Cawthorne

Mob: +44 (0)7584 391 303

N+1 Singer - Nominated Adviser and Broker

+44 (0)20 7496 3000

Richard Lindley

Rachel Hayes

Attachments

  • Original document
  • Permalink

Disclaimer

Surgical Innovations Group plc published this content on 03 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 03 December 2018 09:11:05 UTC